Clinical trials
Neoplasia clinical trials
Below are recruiting neoplasia clinical trials, each written for real people, not researchers. We’re tracking 113 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07444723RecruitingPhase 2/Phase 3
New imaging to find parathyroid tumors before surgery
This study tests two advanced imaging techniques (PET/MR and PET/CT) to find overactive parathyroid glands or tumors that need surgery. Participants get a special scan before surgery to help surgeons locate the problem more accurately.
Bethesda, MarylandAges 18–100 - NCT05078528Recruiting
Low-cost imaging test during cervical follow-up
This study tests a low-cost imaging approach during colposcopy, for people who have abnormal cervical screening results or need follow-up after prior abnormal cells. It may help clinics detect cervical changes more easily and at lower cost.
Porto Alegre, Rio Grande do SulAges 25 years+ - NCT06028672Recruiting
Immunotherapy plus chemotherapy for moderate-risk GTN
This trial tests a combination of an immunotherapy drug (toripalimab) and a chemotherapy drug (actinomycin-D) as the first treatment for gestational trophoblastic neoplasia (GTN) with a FIGO score of 5-6. It may help patients whose disease is at a moderate risk level.
Beijing, Beijing MunicipalityAges 18–60 - NCT07429071Recruiting
Vaginal gel for HPV and early cervical changes
This study tests whether a vaginal gel can help early cervical cell changes (CIN1 or CIN2) go away on their own and clear the HPV virus. If you are being monitored without treatment, this gel might increase your chances of recovery.
HorsensAges 30–50 - NCT04057924Recruiting
Watchful waiting for certain abnormal cells in the cervix
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
BordeauxAges 18 years+ - NCT07412782Recruiting
REMS bone scan study for children with bone conditions
This study uses a new ultrasound technology called REMS to check bone health in children aged 5 to 18 who have conditions that weaken bones. It may help find low bone density without radiation.
Florence, TuscanyAges 5–18 - NCT06169644Recruiting
Emotional effects of chemo for gestational trophoblastic neoplasia
This study looks at the emotional and psychological well-being of women after finishing chemotherapy for gestational trophoblastic neoplasia (GTN). It asks women about their feelings and experiences to better understand and support others going through similar treatment.
Sheffield, South YorkshireAges 16–55 - NCT06862102Recruiting
Multiple HPV Infections and Cervical Lesion Risk
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
Pavia, PaviaAges 18 years+ - NCT05229679Recruiting
HPV screening for women ages 23 to 29
This study focuses on HPV-based screening for women ages 23–29. It may help confirm whether HPV testing is a good way to find early signs of cervical cancer risk in this age group.
Lund, Skåne CountyAges 23–29 - NCT06638866Recruiting
AI screening for pancreatic cancer using regular CT scans
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07275333Recruiting
HPV self-sampling for cervical screening in Ukraine
This trial tests if women can collect their own samples at home to check for HPV, a virus that can cause cervical cancer. It aims to make screening easier during the war in Ukraine.
ZaporizhzhyaAges 30–60 - NCT05284877Recruiting
Study of HPV and skin cancer after organ transplant
This study looks at how human papillomavirus (HPV) and skin cancer behave in people who have had a solid organ transplant. It also includes healthy people for comparison, to understand what might be different after transplant and immune medicines.
Copenhagen NV, Capital RegionAges 18 years+ - NCT06273345Recruiting
Treating the primary tumor for prostate cancer that has spread a little
This trial studies whether treating the main prostate tumor with local therapy (like surgery or radiation) along with hormone therapy is beneficial for men whose cancer has spread to only a few spots in the body (low-volume metastases). It focuses on men who have not had any prior treatment for their prostate cancer.
Brixen, BolzanoAges 18 years+ - NCT07185672RecruitingPhase 3
PRRT with or without chemotherapy for GEP NET
This trial tests whether adding chemotherapy to a standard treatment (PRRT) works better than PRRT alone for people with certain types of digestive tract or pancreatic neuroendocrine tumors. It is for those whose tumors have higher activity on scans or are growing.
Mumbai, MaharashtraAges 18 years+ - NCT06946615RecruitingPhase 1
Claudin18.2 cell therapy for advanced colorectal cancer
This study tests a new treatment using your own immune cells (called CAR-T and CAR-DC) that are engineered to attack cancer cells with a specific protein (Claudin18.2). It is for people with advanced colorectal cancer who have exhausted standard treatments.
Hangzhou, ZhejiangAges 18–70 - NCT07158164RecruitingPhase 4
Genetic testing for chemotherapy dose adjustment
This trial checks if adjusting the dose of chemotherapy drugs 5-FU or capecitabine based on your DPYD genetic results can improve safety and effectiveness. It’s for people with cancer who are about to start these drugs for the first time.
Belleville, New JerseyAges 18 years+ - NCT06962293Recruiting
Magnetic tool for removing early stomach or colon polyps
This trial uses a special magnetic device to help doctors remove early-stage growths in the stomach or colon during a standard procedure called endoscopic submucosal dissection (ESD). The magnet pulls the tissue into a better position, which may make the removal safer and more effective.
Hong KongAges 18–85 - NCT07117045Recruiting
Low-dose CT scan for pancreatic cancer screening
This study uses artificial intelligence to analyze low-dose CT scans of the abdomen to detect early signs of pancreatic cancer. It may help find cancer before symptoms appear.
Shanghai, Shanghai MunicipalityAges 50 years+ - NCT07107334RecruitingPhase 2
GLP-1 drug plus hormone IUD for early endometrial cancer in obesity
This trial tests if adding a GLP-1 weight-loss drug to a hormone-releasing IUD can help treat very early endometrial cancer or a precancerous condition in women with obesity. The goal is to see if this combination is effective without surgery.
Gainesville, FloridaAges 18 years+ - NCT03855592Recruiting
Cancer patients with blood clots: thrombosis and cancer registry
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
Alcoy, AlicanteAges 18 years+ - NCT06982976Recruiting
Light therapy for abnormal cervical or vaginal cells
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
Beijing, Beijing MunicipalityAges 18–65 - NCT06403618Recruiting
Testing PreCursor-M+® for CIN2 management
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
MilanAges 18 years+ - NCT07059819Enrolling by invitation
Local heat therapy for persistent high-risk HPV infection
This study tests whether local heat therapy can help clear a high-risk HPV infection that has lasted at least 3 months. It is for women who have no serious cervical cell changes or only mild changes (CIN) and who are generally healthy.
Shenyang, LiaoningAges 18–65 - NCT06999785Recruiting
Oxygen therapy safety study for radiation treatment side effects
This trial tests whether extra oxygen sessions (hyperbaric oxygen therapy) cause DNA damage in people who have had radiation for cancer. It looks at patients with side effects like bladder or skin issues from past radiation.
AngersAges 18 years+
Hear when a new Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasia?
- Yes. Clin2 currently lists 113 recruiting neoplasia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.